Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Michalakeas, A."'
Autor:
Panagiotopoulos, Alexandros, Fragoulis, George E., Arida, Aikaterini, Bournia, Vassiliki-Kalliopi, Evangelatos, Gerasimos, Fragkiadaki, Kalliopi, Kravvariti, Evrydiki, Laskari, Katerina, Mylona, Maria, Michalakeas, Nikolaos, Papazoglou, Nikolaos, Pappa, Maria, Poulia, Vassiliki, Panopoulos, Stylianos, Ziarangali, Sevastiani, Papatheodorou, Vasileios, Tektonidou, Maria G., Sfikakis, Petros P.
Publikováno v:
Rheumatology International; Sep2024, Vol. 44 Issue 9, p1733-1737, 5p
Autor:
Michalakeas, Christos A., Parissis, John T., Douzenis, Athanasios, Nikolaou, Maria, Varounis, Christos, Andreadou, Ioanna, Antonellos, Nikolaos, Markantonis-Kiroudis, Sophia, Paraskevaidis, Ioannis, Ikonomidis, Ignatios, Lykouras, Evaggelos, Kremastinos, Dimitrios
Publikováno v:
In Journal of Cardiac Failure September 2011 17(9):748-754
Autor:
Christos Michalakeas
Εισαγωγή: Η κατάθλιψη αποτελεί συχνή συννοσηρότητα σε ασθενείς που πάσχουν από χρόνια καρδιακή ανεπάρκεια (ΧΚΑ). Έχουν προταθεί διάφορο
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ee6e972de45e1a7cb02648eb9015a6f
https://doi.org/10.12681/eadd/42398
https://doi.org/10.12681/eadd/42398
Autor:
Panagiotis Angelidakis, Stergios Soulaidopoulos, Georgios Kolovos, Christos A. Michalakeas, Anna Kiourkou, Konstantinos Tsioufis, Charalambos Vlachopoulos
Publikováno v:
The American journal of the medical sciences. 363(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7647ff15254a058e4366b05989a7077
https://pubmed.ncbi.nlm.nih.gov/34672997
https://pubmed.ncbi.nlm.nih.gov/34672997
Background: Azilsartan medoxomil (AZM) is the newest representative in the class of angiotensin receptor blockers. Azilsartan medoxomil in combination with the older diuretic chlorthalidone (CLD) in fixed-doses of AZM/CLD 40/12.5 mg and 40/25 mg has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::d4b1139987cb9e19017dced48f7616c3
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119126
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3119126
Autor:
Christos, Michalakeas, Vasiliki, Katsi, Stergios, Soulaidopoulos, Polychronis, Dilaveris, Dimitrios, Vrachatis, Ioannis, Lekakis, Charalambos, Vlachopoulos, Konstantinos, Tsioufis, Dimitrios, Tousoulis
Publikováno v:
Am J Cardiovasc Dis
The use of mobile health (mHealth) in the field of medicine is constantly evolving and advancing. Arterial hypertension, a major modifiable cardiovascular risk factor with a high prevalence in the general population, frequently remains underdiagnosed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b5e3c303bf90fc738c9e2f1e612fe5aa
https://pubmed.ncbi.nlm.nih.gov/33224593
https://pubmed.ncbi.nlm.nih.gov/33224593
Autor:
Alexios S. Antonopoulos, Christos A. Michalakeas, Vasiliki Katsi, Stergios Soulaidopoulos, Dimitris Tousoulis, Charalambos Vlachopoulos, Konstantinos Tsioufis
Publikováno v:
Current hypertension reviews. 17(3)
Background: Azilsartan medoxomil (AZM) is the newest representative in the class of angiotensin receptor blockers. Azilsartan medoxomil in combination with the older diuretic chlorthalidone (CLD) in fixed-doses of AZM/CLD 40/12.5 mg and 40/25 mg has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc6fdcd54250c079b8014687f9225560
https://pubmed.ncbi.nlm.nih.gov/33438552
https://pubmed.ncbi.nlm.nih.gov/33438552
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Soulaidopoulos, Stergios, Michalakeas, Christos, Angelidakis, Panagiotis, Kolovos, Georgios, Kiourkou, Anna, Tsioufis, Konstantinos, Vlachopoulos, Charalambos
Publikováno v:
In The American Journal of the Medical Sciences January 2022 363(1):84-85